Erik Mittra
Nuclear Medicine · Portland, ORNPI 1841472537
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $62,880 of the $87,176 with a category attached, or 72.1%. 15 manufacturers reported payments, led by Curium US LLC at 25.5% of the total.
Across 79 payments — averaging $1103.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curium US LLC$22K
- Progenics Pharmaceuticals, Inc.$16K
- Sanofi$11K
- Advanced Accelerator Applications$8K
- Ipsen Bioscience Inc.$7K
- Tersera Therapeutics LLC$7K
- plus $16K from 9 others
Across 10 payments — averaging $15,145 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$106K
- Advanced Accelerator Applications$30K
- Novartis$15K
What the payments were for
- Consulting fees$62,88072%
- Speaking & faculty fees$17,63620%
- Travel & lodging$3,6324%
- Food & beverage$3,0283%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Curium US LLC | 32 | $22,261 |
| Progenics Pharmaceuticals, Inc. | 7 | $16,122 |
| Sanofi | 6 | $11,313 |
| Advanced Accelerator Applications | 4 | $7,624 |
| Ipsen Bioscience Inc. | 1 | $7,200 |
| Tersera Therapeutics LLC | 8 | $7,096 |
| Bayer Healthcare LLC | 7 | $6,363 |
| Lantheus Medical Imaging, Inc. | 4 | $4,577 |
| Amgen | 1 | $1,947 |
| Sun Pharmaceutical Industries Inc. | 1 | $1,000 |
| GE HealthCare | 4 | $739 |
| Telix Pharmaceuticals | 1 | $700 |
| Genentech USA, Inc. | 1 | $125 |
| Novartis | 1 | $90 |
| Blue Earth Diagnostics | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AZEDRA$15,925
- Detectnet$9,069
- Lutathera$7,624
- Xermelo$7,053
- Cu64 Dotatate$4,432
- ILLUCCIX$1,400
- BYNFEZIA PEN$1,000
- Avastin$125
- PYLARIFY$125
How this compares
Too few nuclear medicine providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Portland
- Gagandeep ChoudharyPortland$136
- Sebastian ObrzutPortland$40
- Erik YoungEugene$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.